You are here

Article info

Article menu
XML
Oesophagus
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis

Authors

  • Oliver M Fisher Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sarah J Lord Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia NHMRC Clinical Trials Centre University of Sydney, Sydney, New South Wales, Australia Department of Epidemiology and Medical Statistics, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Dan Falkenback Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia Department of Surgery, Lund University Hospital (Skåne University Hospital) and Lund University, Lund, Sweden PubMed articlesGoogle scholar articles
  • Nicholas J Clemons Cancer Biology and Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Guy D Eslick The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Reginald V Lord Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia Department of Surgery, School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Oliver M Fisher, Gastroesophageal Cancer Research Group, St Vincent's Centre for Applied Medical Research, 405 Liverpool Street, Sydney NSW 2010, Australia; ofisher{at}gmx.ch
View Full Text

Citation

Fisher OM, Lord SJ, Falkenback D, et al
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
Gut 2017;66:399-410.

Publication history

  • Received October 12, 2015
  • Revised November 23, 2015
  • Accepted December 4, 2015
  • First published January 5, 2016.
Online issue publication 
December 13, 2018

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/